Hormones and acne: Pathophysiology, clinical evaluation, and therapies

Seminars in Cutaneous Medicine and Surgery

Volumn 20, Issue 3, 2001, Pages 144-153

  Thiboutot, D ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; AZELAIC ACID; BENZOYL PEROXIDE; BUSERELIN; CLINDAMYCIN; CORTICOSTEROID; CYPROTERONE ACETATE; DEXAMETHASONE; DIANE; ERYTHROMYCIN; ESTROGEN; ETHINYLESTRADIOL PLUS LEVONORGESTREL; ETHINYLESTRADIOL PLUS NORETHISTERONE ACETATE; ETHINYLESTRADIOL PLUS NORGESTIMATE; FLUTAMIDE; GLUCOCORTICOID; GONADORELIN AGONIST; GROWTH HORMONE; HORMONE; ISOTRETINOIN; LEUPRORELIN; NAFARELIN; ORAL CONTRACEPTIVE AGENT; PREDNISONE; RETINOID; SPIRONOLACTONE; STEROID 5ALPHA REDUCTASE INHIBITOR;

ACNE; ADULT; CLINICAL EXAMINATION; CLINICAL TRIAL; DIAGNOSTIC APPROACH ROUTE; DRUG INDUCED DISEASE; ENDOCRINE DISEASE; FEMALE; HORMONAL THERAPY; HORMONE METABOLISM; HUMAN; KERATINIZATION; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; REVIEW; SEBUM;

EID: 0034809828     PISSN: 10855629     EISSN: None     Source Type: Journal    
DOI: 10.1053/sder.2001.28208     Document Type: Review

References (50)

1. Inocoterone and acne
2. Androgen control of the pilosebaceous duct?
3. Activity of type 1 5α-reductase is greater in the follicular infrainfundibulum compared with the epidermis
4. Localization of androgen receptors in human skin by immunohistochemistry: Implications for the hormonal regulation of hair growth, sebaceous glands and sweat glands
5. Immunocytochemical localization of androgen receptors in human skin using monoclonal antibodies against the androgen receptor
6. Acne vulgaris in premenarchal girls
7. Sebaceous gland activity and serum dehydroepiandrosterone sulfate levels in boys and girls
8. The androgen control of sebum production. Studies of subjects with dihydrotestosterone deficiency and complete androgen insensitivity
9. Sebaceous gland response in man to the administration of testosterone, D4-androstenedione, and dehydroisoandrosterone
10. Androgen excess in cystic acne
11. Plasma androgens in women with acne vulgaris
12. Effect of androgen on the sebaceous glands of human skin
13. Is the metabolism of testosterone to 5a-dihydrotestosterone required for androgen action in the skin?
14. Tissue production of androgens in women with acne
15. Differential rates of conversion of testosterone to dihydrotestosterone in acne and in normal human skin - A possible pathogenic factor in acne
16. Histochemical distribution of hydroxysteroid dehydrogenases in human skin
17. D5-3b-hydroxysteroid dehydrogenase activity in sebaceous glands of scalp in male-pattern baldness
18. 4-5-isomerase in human sebaceous glands and their secretory activity in vivo
19. The 3β-hydroxysteroid dehydrogenase gene family of enzymes
20. Physiology and molecular genetics of 17β-hydroxysteroid dehydrogenases
21. Oxidative activity of the type 2 isozyme of 17b-hydroxysteroid dehydrogenase (17b-HSD) predominates in human sebaceous glands
22. Human skin androgen metabolism and preliminary evidence for its control by two forms of 17 β-hydroxysteroid oxidoreductase
23. Enzymes of carbohydrate metabolism in normal human sebaceous glands
24. Genetic and pharmacological evidence for more than one human steroid 5a-reductase
25. Activity of the type 1 5α-reductase exhibits regional differences in isolated sebaceous glands and whole skin
26. Androgen metabolism in sebaceous glands from subjects with and without acne
27. The insulin-like growth factor I receptor is expressed by epithelial cells with proliferative potential in human epidermis and skin appendages: Correlation of increased expression with epidermal hyperplasia
28. Keratinocyte growth factor is an important endogenous mediator of hair follicle growth, development and differentiation
29. Stimulation of all epithelial elements during skin regeneration by keratinocyte growth factor
30. The activity of HMG-CoA reductase and acetyl-CoA carboxylase in human apocrine sweat glands, sebaceous glands, and hair follicles is regulated by phosphorylation and by exogenous cholesterol
31. Effect of cyclic progestin-estrogen therapy on sebum and acne in women
32. Different levels of 5α-reductase type I and II, aromatase, and androgen receptor in hair follicles of women and men with androgenetic alopecia
33. Role of androgens in the developmental biology of the pilosebaceous unit
34. Hormonal therapy of acne
35. Evaluation of a new generation of oral contraceptives
36. Effectiveness of norgestimate and ethinyl estradiol in treating moderate acne vulgaris
37. Norgestimate and ethinyl estradiol in the treatment of acne vulgaris: A randomized, placebo-controlled trial
38. Effect of low-dose oral contraceptives on androgenic markers and acne
39. Hormones and acne
40. Sebaceous gland suppression in female acne patients by combined glucocorticoid-oestrogen treatment
41. Sebaceous gland inhibition from combined glucocorticoid-estrogen treatment
42. Treatment with a gonadotropin-releasing hormone agonist in acne or idiopathic hirsutism
43. Oral spironolactone improves acne vulgaris and reduces sebum excretion
44. Spironolactone in dermatologic therapy
45. Hormonal therapy for acne
46. Low-dose adjunctive spironolactone in the treatment of acne in women: A retrospective analysis of 85 consecutively treated patients
47. Experience in the long term treatment of patients with hirsutism and/or acne with cyproterone acetate-containing preparations
48. Treatment of hirsutism with the pure antiandrogen flutamide
49. Fatal and nonfatal hepatotoxicity associated with flutamide
50. The 5 alpha-reductase system and its inhibitors. Recent development and its perspective in treating androgen-dependent skin disorders